These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Pathogenic importance of cysteinyl leukotrienes in development of gastric lesions induced by ischemia/reperfusion in mice. Nakamori Y; Komatsu Y; Kotani T; Kojima S; Takeuchi K J Pharmacol Exp Ther; 2010 Apr; 333(1):91-8. PubMed ID: 20042530 [TBL] [Abstract][Full Text] [Related]
12. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor. Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602 [TBL] [Abstract][Full Text] [Related]
13. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. Knapp HR N Engl J Med; 1990 Dec; 323(25):1745-8. PubMed ID: 1701029 [TBL] [Abstract][Full Text] [Related]
14. Lipid mediators in the rat retina: light exposure and trauma elicit leukotriene B4 release in vitro. Reinboth JJ; Gautschi K; Clausen M; Remé CE Curr Eye Res; 1995 Nov; 14(11):1001-8. PubMed ID: 8585927 [TBL] [Abstract][Full Text] [Related]
15. Effects of peripherally and centrally applied ghrelin in the pathogenesis of ischemia-reperfusion induced injury of the small intestine. Pawlik MW; Obuchowicz R; Biernat J; Szczepanski W; Pajdo R; Kwiecień S; Brzozowski T; Konturek SJ; Pawlik WW J Physiol Pharmacol; 2011 Aug; 62(4):429-39. PubMed ID: 22100844 [TBL] [Abstract][Full Text] [Related]
16. Neutrophil lipoxygenase activation and leukosequestration in postischemic myocutaneous flaps: role of LTB4. Kirschner RE; Chiao JJ; Fyfe BS; Hoffman LA; Davis JM; Fantini GA Am J Physiol; 1995 Jun; 268(6 Pt 2):H2167-74. PubMed ID: 7611467 [TBL] [Abstract][Full Text] [Related]
17. Characterization of LY233569 on 5-lipoxygenase and reperfusion injury of ischemic myocardium. Hahn RA; MacDonald BR; Simpson PJ; Wang L; Towner RD; Ho PP; Goodwin M; Breau AP; Suarez T; Mihelich ED J Pharmacol Exp Ther; 1991 Jan; 256(1):94-102. PubMed ID: 1988671 [TBL] [Abstract][Full Text] [Related]
18. New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis. Boudreau LH; Lassalle-Claux G; Cormier M; Blanchard S; Doucet MS; Surette ME; Touaibia M Mediators Inflamm; 2017; 2017():6904634. PubMed ID: 28680195 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase. Rubin P; Dubé L; Braeckman R; Swanson L; Hansen R; Albert D; Carter G Agents Actions Suppl; 1991; 35():103-16. PubMed ID: 1781415 [TBL] [Abstract][Full Text] [Related]
20. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification]. Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]